Recordati Makes Good Start to 2022 As Cold & Flu Sales Rebound
Executive Summary
Italy's Recordati reports a double-digit rise in OTC sales for the first quarter of 2022, reflecting improved sales of cold & flu products and dietary supplements, particularly in France and its domestic market.
You may also be interested in...
Recordati Posts 2021 Sales Rise As Market Recovers
Italy's Recordati attributed a solid rise in OTC sales in 2021 to the recovery of the European market as the COVID-19 pandemic loosened its grip.
Sun Pharma Grows OTC Offering In Romania With Uractiv Brand Acquisition
India's Sun Pharma has expanded the portfolio of its Romanian subsidiary Terapia with the acquisition of the Uractiv urinary tract health brand.
Futura Pens Deal With Cooper To Launch Erectile Dysfunction Gel In Europe
Futura Medical's novel OTC topical erectile dysfunction treatment MED3000 will be launched across numerous European markets by France's Cooper Consumer Health.